AMMONIA AMINATION

By developing a stable nickel catalyst system, a Canadian research team has fulfilled a quest to move beyond using expensive palladium catalysts in cross-coupling reactions to make aryl amines from ammonia. The approach taken by Andrey Borzenko, Mark Stradiotto, and coworkers of Dalhousie University, in Halifax, Nova Scotia, is expected to find quick adoption in the pharmaceutical industry, where it would be used to help synthesize complex drug candidates.

Ammonia is the simplest and most abundant N–H source in chemistry—virtually all synthetic nitrogen-containing compounds originate from the inexpensive feedstock. Industrial syntheses of amines from ammonia, however, typically require heterogeneous catalysts at relatively high temperatures and pressures, resulting in modest product selectivity. Only recently have chemists devised homogeneous palladium catalysts for the task, which allow for more selective ammonia couplings under milder conditions.

The Dalhousie team’s method is the first example of nickel-catalyzed arylation of ammonia to make amines. The researchers used Ni(cyclooctadiene) 2 or NiCl 2 (dimethoxyethane) with a ferrocenyl phosphine ligand known as JosiPhos to link up a range of substituted aryl and heteroaryl bromides, chlorides, and tosylates with ammonia to make diverse aryl and heteroaryl amines (Angew. Chem. Int. Ed. 2015, DOI: 10.1002/anie.201410875).

“Catalysis with nonprecious metals is one of our primary goals in the pharmaceutical industry,” says Robert A. Singer, a process chemist at Pfizer. There are a number of attributes to like about the new work, Singer notes. Nickel is much more abundant and less expensive to use than palladium. The new catalyst is also air stable and less susceptible to ammonia deactivation or ligand dissociation.

Sign up for C&EN's must-read weekly newsletter Email Address * Subscribe » Contact us to opt out anytime